植物化学物质Withanolide N和Dryyobalanolide作为潜在的生物活性导致开发针对氨酸蛋白激酶Mer的抗癌药物
Afzal Hussain1, Taj Mohammad2, Mehak Gulzar2
1Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Omics : a journal of integrative biology
|January 10, 2025
概括
两种天然化合物,withanolide N和dryobalanolide,显示出潜在的抗癌药物,向氨酸蛋白激酶Mer. 需要进一步的研究来评估它们在癌症治疗中的有效性和安全性.
科学领域:
- 自然产品化学 自然产品化学
- 计算机化药物发现.
- 在瘤学瘤学.
背景情况:
- 植物化学物质越来越多地被用于抗癌药物开发.
- 受体氨酸激酶 (RTKs),特别是TAM家族成员Mer,对于癌症和耐药性至关重要.
- 氨酸蛋白激酶Mer与癌症易感性和转移有关.
研究的目的:
- 识别潜在的植物化学物质,以色素蛋白激酶Mer为向,用于抗癌药物开发.
- 评估选择的天然化合物的药物相似性和结合潜力.
主要方法:
- 综合虚拟选和模拟IMPPAT 2.0植物化学库.
- 物理化学性质分析,结合亲和度计算和PAINS过.
- 在基分子动力学模拟,PCA和自由能源景观分析.
主要成果:
- 鉴定出withanolide N和dryobalanolide是潜在的生物活性向氨酸蛋白激酶的潜在向物.
- 这些化合物通过广泛的in silico分析证明了药物开发的有利性质.
结论:
- 维他诺化N和干性聚化值得进一步研究作为新型抗癌剂.
- 建议进行体外和体内研究,以验证其在瘤学中的治疗疗效和安全性.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.1K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
